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ABSTRACT
Background: The long-term primary patency rates for percutane-
ous transluminal angioplasty using first and second generation 
stents for the treatment of the popliteal artery have been disap-
pointing. However, results with the new nitinol stents seem 
promising. Our objective was to evaluate short-term clinical 
outcomes using the superflexible nitinol stent in the treatment 
of atherosclerotic lesions in popliteal segments. Methods: 
Retrospective longitudinal study conducted from April to De-
cember 2013. Population characteristics, procedure-related data 
and imaging tests were assessed at 6 months. Stent patency 
and limb salvage rates were obtained. Results: A total of 14 
patients with mean age of 73 ± 11 years were included, of 
which 50% were male and 64.3% diabetic. All patients had 
trophic lesions in the treated limbs. The arteriographic lesions 
were classified according to the criteria of the Trans-Atlantic 
Inter-Society Consensus (TASC) criteria  as TASC B and C in-
equal proportions. In the assessment of below-the-knee runoff, 
78.6% of the patients had only one distal pervious artery, of 
which the fibular artery was the most frequently observed.
The stent landing zone was the mid segment of the popliteal 
artery in 57.1% of the cases and the distal segment, crossing 
the knee joint, in the remaining patients. During the 6 month 
follow-up there were no stent fractures. The primary patency 
rate was 85.7% and the limb salvage rate was 100%. Conclu-
sions: In our study, angioplasty using the super flexible nitinol 
stent demonstrated to be safe and effective for the treatment 
of atherosclerotic lesions of the popliteal artery.
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RESUMO
Resultados do Uso de Stent de Nitinol  
Superflexível em Artérias Poplíteas
Introdução: As taxas de patência primária no longo prazo 
para a angioplastia transluminal percutânea, com implante 
de stents de primeira e segunda geração, no tratamento da 
artéria poplítea, têm sido desapontadoras. No entanto, re-
sultados com novos stents de nitinol parecem promissores. 
Nosso objetivo foi avaliar desfechos clínicos no curto prazo 
do uso de stents de nitinol superflexíveis no tratamento de 
lesões ateroscleróticas nos segmentos poplíteos. Métodos: 
Estudo retrospectivo, longitudinal, realizado no período de 
abril a dezembro de 2013. Foram avaliados as característi-
cas populacionais, os dados do procedimento e os exames 
de imagem aos 6 meses, sendo obtidas as taxas de patência 
do stent e de salvamento de membro. Resultados: Incluímos 
nesta análise, 14 pacientes, com idade de 73 ± 11 anos, 50% 
do sexo masculino e 64,3% diabéticos. Todos os pacientes 
apresentavam lesão trófica nos membros tratados. As lesões 
arteriografias foram classificadas pelo critério Trans-Atlantic 
Inter-Society Consensus (TASC) em B e C em igual proporção. 
Na avaliação do leito de escoamento, 78,6% dos pacientes 
possuíam apenas uma artéria pérvia, sendo a artéria fibular a 
mais frequentemente observada. As zonas de aterrissagem dos 
stents foram o segmento médio da artéria poplítea em 57,1% 
dos casos e, nos demais, o segmento distal da artéria, cruzando 
a articulação do joelho. Durante o seguimento de 6 meses, 
não foram observadas fraturas dos stents. A taxa de patência 
primária foi de 85,7% e a de salvamento do membro foi de 
100%. Conclusões: A angioplastia com uso de stent de nitinol 
superflexível demonstrou ser segura e efetiva no tratamento 
das lesões ateroscleróticas da artéria poplítea.
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L ower-limb revascularization with the use of stents for the treatment of peripheral obstructive arterial disease (POAD) is usually restricted to segments 
not submitted to external compression, or to regions 
without mobility, due to the complex mechanisms of 
forces acting on the vessels, with generation of consid-
erable biomechanical stress, especially in the popliteal 
artery.1 Even today, the results are not ideal, with stents 
of first and second generation showing patency rates 
below those of conventional surgical treatment. The 
rates of stent fracture, when the device is implanted 
in the popliteal artery, range from zero to 65% in dif-
ferent cohorts.2
A new generation of more flexible and resistant 
stents3,4 has shown comparable results, in the short-and 
medium-term, versus surgical treatment, which is still 
considered the standard technique for the treatment of 
these lesions.1 With the development of third-generation 
superflexible stents, endoluminal therapy has increas-
ingly replaced surgical revascularization.4-6
This study aimed to evaluate the clinical outcomes 
in the short-term use of superflexible nitinol stents in 
the treatment of atherosclerotic lesions of popliteal 
segments.
METHODS
Study type
This was a retrospective, longitudinal, observational 
study in a referral center for cardiovascular diseases, 
conducted in the period from April to December 2013. A 
total of 66 patients underwent angioplasty with stenting 
of the lower limbs, with 14 cases in the popliteal artery.
Inclusion and exclusion criteria
Patients of both genders, with limiting intermittent 
claudication, pain at rest in the affected limb or with 
ipsilateral trophic lesion, and with lesions restricted 
to the popliteal artery and the presence of at least 
one leg artery for distal run-off, were treated. Patients 
with creatinine clearance <  30 mL/kg/min, history of 
severe allergy to iodinated contrasts, and those with 
significant atherosclerotic disease in aortoiliac and/or 
femoral territories were excluded from the procedures. 
Preoperative arteriography was used to classify the 
lesions according to: (1) the Trans-Atlantic Inter-Society 
Consensus II (TASC-II) 7 criteria: A, B, C, or D (Box); 
(2) type of lesion: stenosis, occlusion, dissection, or 
restenosis; and (3) location relative to the articular line: 
proximal, middle, or distal (Figure 1).
Endovascular procedure
All procedures were performed by the same team at 
the Hemodynamics Laboratory, Center for Endovascular 
Interventions, Instituto Dante Pazzanese de Cardiologia. 
Clopidogrel (75 mg/day) and acetylsalicylic acid 
(100 mg) were started at least three days before the 
procedure. Clopidogrel was maintained for at least 30 
days and acetylsalicylic acid was maintained indefinitely. 
BOX 
Classification of lesions according to the  
Trans-Atlantic Inter-Society Consensus II (TASC II)
A  Lesions that produce the best results and that should 
be treated by endovascular route.
B  Lesions that produce sufficiently good results 
with endovascular methods, so that this is 
still the preferred approach, unless surgical 
revascularization is required to treat other lesions in 
the same anatomic area.
C  Lesions exhibiting superior long-term results with 
surgery, so that endovascular methods should be 
used only in patients at high surgical risk.
D  Lesions that do not produce good enough results 
with endovascular methods to justify them as 
primary treatment.
Figure 1 – Schematic representation of the segments of popliteal artery. 
P1 corresponds to the proximal segment, from the channel of adductor 
muscles to the upper border of patella; P2 is the middle segment, from 
the upper border of patella to the joint line; P3 corresponds to the distal 
segment, from the joint line to the emergence of anterior tibial artery.
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The participants were treated with local anesthetic, 
and antimicrobial prophylaxis was performed with 1.5 g 
of cefuroxime immediately before the beginning of the 
procedure. Radiographic control was obtained with an 
AXIOM Artis Flat Panel device (Siemens Healthcare 
Sector, Forchheim, Germany) or in a hybrid room 
with a Zeego Artis device (Siemens Healthcare Sector , 
Forchheim, Germany).
The approach was preferentially performed through 
the ipsilateral common femoral artery, with anterograde 
puncture, using a Prelude® (Merit Medial Systems, South 
Jordan, United States) 6 F valved sheath. In the case of 
impossibility of using this access route, or when it was 
not possible to cross the target lesion, a retrograde ac-
cess by puncturing one of the leg arteries was chosen, 
with a Prelude®4 F valved sheath. 5 F MPA-1 and/or 4 F 
STR diagnostic catheters (Cordis Corporation, Warren, 
United States) were used, and the crossing of target 
lesions was performed by luminal or sub-intimal route, 
with the help of a Radiofocus® (Terumo Interventional 
Systems, Somerset, United States) hydrophilic guide 
wire (wire size, 0.035” × 150  cm). Pre-dilation was 
conducted in cases of occlusion, or when a proper 
positioning of the stent was not possible. In all cases, 
the sinus-SuperFlex® (Optimed, Ettlingen, Germany) 
nitinol stent was used (Figure 2).
In all cases, the immediate postoperative period oc-
curred in the ward, and local hemostasis was performed 
with manual compression for 30 minutes.
Postoperative follow-up 
The follow-up was performed with outpatient evalua-
tion, consisting of physical examination and ankle-brachial 
index (ABI) determination at 15, 30, 90, and 180 days 
after angioplasty. The control with Doppler ultrasound 
(USG-D) was performed at 30, 90, and 180 days after 
surgery, with the aim of identifying restenoses (Figure 3). 
Radiographs of the knee joint in posteroanterior (PA) and 
lateral views were performed at 30 and 180 days, with 
the aim of identifying stent fractures (Figure 4).
Outcomes and definitions 
The analyzed outcomes were: (1) immediate technical 
success, when the target lesion was treated in the man-
ner previously planned, with residual lesion <  30% in 
the angiographic control; (2) primary patency, indicating 
an uninterrupted permeability after the revascularization 
procedure; and assisted primary patency, indicating cases 
where a new percutaneous intervention was applied, in 
order to prevent the impending occlusion or the progres-
sion of stenosis; (3) perioperative morbidity/mortality, for 
complications and deaths recorded for up to 30 days 
postoperatively; (4) major amputation: transfemoral and 
transtibial amputations; (5) restenoses, for in-stent lesions 
>  50% detected with USG-D, with peak systolic veloc-
ity >  200  cm/s or a pre-and post-stenosis rate ≥  2; (6) 
fractures, for disconnection or twisting of stent meshes; 
and (7) rate of limb salvage.
RESULTS
Fourteen patients with symptomatic POAD, treated 
with primary angioplasty (without employing other 
adjuvant methods of arterial unblocking) with stent 
implantation in popliteal arteries, were included in 
the study.
Characteristics of the population 
The demographic characteristics, comorbidities, 
and indications for treatment are described in Table 1. 
Mean age was 73 ± 11 years, 50% of patients were 
male, and approximately two-thirds were diabetic. The 
left leg was the most frequently treated limb (57.1%) 
and all patients had trophic lesions with tissue loss. 
Patients with intermittent claudication or pain at rest 
were not treated.
Characteristics of lesions and of procedure 
The lesions were classified into TASC B (50%) and 
C (50%). Regarding their location, 71.4% of cases were 
in the proximal segment of popliteal artery (P1), and in 
Figure 2 – Angioplasty of popliteal artery with landing zone in the distal segment of this artery. (A) Digital subtraction arteriogram showing occlusion 
of popliteal artery with distal filling in the interline. (B) Pre-dilation. (C) Positioning of the stent in the distal segment of popliteal artery. (D) Final 
arteriogram with return of axial flow. (E) Arteriography in leg flexion, without exhibiting kinking or blood flow-limiting injuries.
A B C D E
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28.6% of the cases were in middle or distal segments, 
in equal proportion (P2 and P3). In eight cases (57.1%), 
the stents were implanted in previously occluded ves-
sels, with pre-dilation performed in all lesions. 
In the evaluation of the run-off bed, the majority 
of patients had only one patent artery (78.6%) and 
the fibular artery was the most frequently observed. 
A mean of 1.3 ± 0.4 arteries by treated limb was 
obtained (Table 2).
It was possible to achieve the target lesion re-
vascularization in all cases with the use of one stent, 
obtaining technical success in 100%. The average extent 
of lesion coverage was 177 ± 18 mm (120-200 mm). 
Ten stents (71.4%) with a diameter of 6 mm and four 
stents (28.6%) with a diameter of 5  mm were used. 
There were no cases of intraoperative dissection or 
embolization. The areas of more frequent stent land-
ing were the middle segment of popliteal artery (P2) 
in eight cases (57.1%) and the distal segment (P3) of 
the artery, crossing the joint knee, in six cases (42.9%). 
No implants occurred in the proximal segment (P1). 
Mean procedure times and of radioscopy were, re-
spectively, 55 ± 43 minutes (range 20-240 min) and 
Figure 3 – Ultrasonographic control at 6 months of stenting in the middle segment of popliteal artery. (A) Color-mode image without signs sugges-
tive of stent fracture. (B) Color-mode image, showing laminar flow without vortices and no signs of neointimal hyperplasia. (C) Doppler Ultrasound 
demonstrating spectral curve of speed in native artery. (D) Doppler Ultrasound demonstrating spectral curve of intra-stent speed with a velocity of 
70 cm/s and a speed ratio of 1. 
Figure 4 – (A) Radiography of knee in semi-flexion, with no signs of 
stent twisting or fracture. (B) Radiography of knee in posteroanterior 
view and with no signs of fracture. (C) Radiography of knee without 
evidence of compression at the level of adductor canal.
A
C D
B
A B C
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19 ± 14 minutes (range 5-66 min). The mean volume 
of iodinated contrast used was 88 ± 41 mL. In one 
case, a distal retrograde access by the dorsalis pedis 
artery was performed, thanks to the impossibility of 
crossing the target lesion by the anterograde technique. 
No complications with respect to the puncture site 
(Table 3) were observed.
Patient follow-up 
The mean follow-up was 6.4 ± 2.1 months (range 
3.2 to 8.4 months). There were no intraoperative or 
procedure-related deaths. Ninety days post-procedure, 
one elderly patient died due to cardiac complications. 
The limb salvage rate was 100%. There was no 
major amputation during the follow-up. In three pa-
tients (21.4%), there was a development of their trophic 
lesions; two of these lesions were caused by in-stent 
stenoses in the 60th and 90th day of follow-up, and were 
treated by balloon dilation. The third injury occurred 
due to infectious complications, which resulted in a 
minor amputation. There was an increase of ABI, from 
0.4 ± 0.15 preoperatively to 0.8 ± 0.13 at the time of 
hospital discharge.
The primary patency rate was 85.7% at 6 months. 
In two cases, it was necessary to perform a new balloon 
angioplasty for treatment of in-stent restenosis, with 
therapeutic success in only one case. This resulted in 
an assisted primary patency rate of 92.8% at follow-up. 
There were no stent fractures documented by radiographs 
of the knee joint.
DISCUSSION
The management of atherosclerotic lesions in the 
segments of the popliteal artery near the knee joint 
represents a difficult endovascular approach, because 
of the biomechanical stresses occurring in this region. 
Complex rotational, tensile, compressive, and stretching 
forces act simultaneously on a short arterial segment 
TABLE 1 
Baseline clinical characteristics
Variable n = 14
Age, years 73 ± 11
Male gender, n (%) 7 (50)
Body mass index, kg/m2 25.3 ± 5.5
Hypertension, n (%) 14 (100)
Diabetes mellitus, n (%) 9 (64.3)
Dyslipidemia, n (%) 14 (100)
Smoking, n (%) 7 (50)
Previous acute myocardial infarct, 
n (%) 
2 (14.3)
Alcohol abuse, n (%) 4 (28.6)
Laterality, n (%) 
Right 6 (42.9)
Left 8 (57.1)
Indication for the procedure, n (%) 
Trophic lesion 14 (100)
Pain at rest 0
Intermittent claudication 0
Creatinine, mg/dL
Preoperative 0.8 ± 0.6
Postoperative 0.9 ± 0.5
Ankle-brachial index 
Preoperative 0.4 ± 0.15
Postoperative 0.8 ± 0.13
TABLE 3 
Characteristics of the procedure
Variable n = 14
Procedure time, min 55 ± 43
Radioscopy time, minutes 19 ± 14
Contrast volume, mL 88 ± 41
Stent characteristic 
Diameter, mm 7 ± 0.5
Length, mm 177 ± 18
Stent location 
P1 0
P2 8 (57.1)
P3 6 (42.9)
TABLE 2 
Angiographic characteristics of lesions
Variable n = 14
TASC, n (%) 
A 0
B 7 (50)
C 7 (50)
D 0
Characteristic, n (%) 
Stenosis 6 (42.9)
Occlusion 8 (57.1)
Location, n (%) 
Popliteal and femoral 10 (71.4)
Popliteal 4 (28.6)
Arteries for flow, n (%) 
1 11 (78.6)
2 2 (14.3)
3 1 (7.1)
TASC: Trans-Atlantic Inter-Society Consensus II (TASC – II).7
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and on the stent.8,9 For many years, these lesions were 
treated by surgical grafting using autologous vein, with 
rates of primary and secondary patency after 5 years of 
63% to 75% and 80% to 83%, respectively, and with a 
perioperative mortality of 1% to 3%.10-12 However, these 
high patency and low mortality rates are accompanied 
by a considerable perioperative morbidity, as are the 
subsequent multiple surgical procedures and hospital 
readmissions.13
Currently, with the development and improvement of 
endovascular materials, the number of minimally invasive 
procedures for the treatment of popliteal lesions has 
increased. Generally, balloon angioplasty, or mechani-
cal or laser arterectomy, are the preferred choices for 
the treatment of arterial lesions behind the knee, due 
to the lack of metallic devices capable of withstanding 
the forces exerted on this arterial segment.14,15 However, 
the efficacy of these techniques is limited.15
The first large study comparing treatment with bal-
loon angioplasty versus stenting in the femoropopliteal 
segment was RESILENT2 (Randomized Study Comparing 
the Edwards Self-ExpandIng Lifestent versus Angioplasty 
Alone In LEsions INvolving The SFA and/or Proximal 
Popliteal Artery). During the first phase of this study, 
patients with intermittent claudication because of femo-
ropopliteal occlusive lesions, with length < 15 cm and 
diameter of the target vessel between 4 to 6.5  mm, 
were included. The results showed the superiority of 
the LifeStent® (Bard Peripheral Vascular, Tempe, United 
States) over balloon angioplasty in the femoropopliteal 
segment. In its second phase, 206 patients were included, 
when the treatment of more than one lesion was al-
lowed, provided they did not exceed the length of 15 
cm. Its primary endpoint was the revascularization of 
the target vessel within 12 months. The result was a 
primary patency of 80% vs. 38% for the LifeStent® vs. 
balloon angioplasty, respectively.3
The choice of the stent depends on the anatomic 
characteristics of the lesion, such as its location and 
the extent of calcification, as well as the characteristics 
of the stent – its diameter, length, profile, flexibility, 
long-term durability, and resistance to fracture. The limi-
tations to stent implant in the popliteal artery include 
insufficient radial force to maintain the patency of the 
vessel, and the possibility of folding and fractures of the 
device. Stent fracture is associated with high incidence 
of restenoses and occlusions. Scheinert et al.16 detected 
radiographically 64 fractures in 261 stents (24.5%) used 
in the treatment of femoropopliteal lesions. The primary 
patency rate obtained in the 12 months’ follow-up was 
significantly lower in patients with fracture (41.1% vs. 
84.3%, p < 0.0001). In the present study, stent fractures 
detected by the same method were not observed.
Regarding the rate of primary patency, the results 
of several studies in the literature considered hetero-
geneous populations, also differing in the location of 
the segments treated. Chan et al.4 reported primary 
patency rates of the femoropopliteal stent implanted 
in the segment after six and 12 months of 83.5% and 
78.6%, respectively, in 82 limbs treated with Supera® 
stent (IDEV Technologies Inc., Webster, United States). 
In the Durability-200 study, Bosiers et al.17 analyzed 
100 patients, 71% of whom were treated for intermittent 
claudication and 29% treated for critical ischemia, with 
their injuries classified as TASC C and D, and used the 
devices in the femoropopliteal segment. These authors 
obtained a primary patency of 85.4% at 6 months and 
of 64.8% at 12 months. As for stents implanted in the 
popliteal segment, Kickuth et al.18 studied 35 patients 
with intermittent claudication and critical limb ischemia, 
in which auto-expandable nitinol stents were implanted 
in the popliteal artery. In 22 cases, stents were implanted 
in the distal portion of the popliteal artery, and in the 
other cases, in the tibiofibular trunk, with a primary 
patency rate of 82% and a limb salvage rate of 100%. 
In the present study, most stents were implanted in the 
middle segment, and in only six cases (42.9%), stents 
were implanted in the distal segment, crossing the joint 
line. A primary patency and an assisted primary patency 
of 85.7% and 92.8% were obtained, respectively, at 
the six-month follow-up, in a population consisting of 
patients with critical ischemia of Rutherford classes 5 
and 6, and in arteriographic lesions classified as TASC 
B and C, with a similar rate of limb salvage. 
During the clinical follow-up, there was improve-
ment in ABI, from 0.4 ± 0.15 preoperatively to 0.8 ± 
0.13 at the time of hospital discharge, as well as an 
improvement of trophic lesions in 78.6% of cases. The 
measurement of ABI may have been overestimated, due 
to the high prevalence of diabetes in our population 
(64.3%), considering that the predominance of arte-
rial calcifications in the distal portions of leg arteries 
of diabetic people overestimates the mensuration of 
this index.
Study limitations
The small number of cases, the heterogeneous group 
of segments treated in the popliteal artery, the short 
follow-up period, and the absence of an established 
algorithm for clinical follow-up may have influenced 
the results of this study. Finally, the accuracy of the 
results may have been affected by the retrospective 
data analysis.
CONCLUSIONS
In this study, it was demonstrated that angioplasty 
with use of a superflexible nitinol stent is a safe and 
effective procedure in the treatment of atherosclerotic 
lesions in popliteal arteries. The patency rates obtained 
in various segments of the popliteal artery treated 
demonstrate the need for a close clinical follow-up of 
these patients in the medium and long term.
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